Dana-Faber Cancer Institute
Dana-Faber Cancer Institute
Boston, Massachusetts, United States2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression | Castration Resistant Metastatic Prostate Cancer | Recruiting | Phase 2 | 2026-07-17 | NCT04363164 | |
| A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors | Solid Tumor, Adult | Recruiting | Phase 1 / Phase 2 | 2026-01-08 | NCT06265727 |